Search

Your search keyword '"Heuvel, M. van den"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Heuvel, M. van den" Remove constraint Author: "Heuvel, M. van den"
142 results on '"Heuvel, M. van den"'

Search Results

101. Schoolsport in Nederland

103. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]

104. Identification of common variants associated with human hippocampal and intracranial volumes.

107. Structure and properties of polydiacetylene-containing peptide amphiphile fibres

108. De relatie tussen werkhulpbronnen, werkbevlogenheid en veranderprestatie

109. Mechanical and thermal stabilities of peptide amphiphile fibres

110. Delivery of DNA and siRNA by novel gemini-like amphiphilic peptides

111. Stimulus responsive peptide based materials

113. Taking a sneak in the black box: How change resources are related to positive organizational outcomes

114. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.

116. The development of the Default Network: An overview from childhood to old age

117. Patterns of Diacetylene-Containing Peptide Amphiphiles Using Polarization Holography

118. Nieuwe ruimte in een sportieve stad

120. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone.

121. z.t

123. Effecten van de betuweroute op NOx- en CO2-emissies

124. z.t.

125. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions

132. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.

133. Molecular PET imaging to steer treatment for cancer patients

134. Current and novel methods to measure dynamic hyperinflation in patients with COPD - Accuracy and usability in telemonitoring

135. Pemetrexed-based chemotherapy for lung cancer treatment The delicate balance between efficacy and toxicity

136. The COPDnet integrated care model: a newly developed and effective care pathway for patients with Chronic Obstructive Pulmonary Disease

137. LBA3 Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC.

Catalog

Books, media, physical & digital resources